Ritonavir 100 MG Oral Tablet Norvir
1 INDICATIONS AND USAGE NORVIR tablets and oral solution are indicated in combination with other antiretroviral agents for the treatment of HIV-1 infection. NORVIR oral powder is indicated in combination with other antiretroviral agents for the treatment of pediatric patients with HIV-1 infection. NORVIR tablets and oral solution are HIV protease inhibitors indicated in combination with other antiretroviral agents for the treatment of HIV-1 infection ( 1 ) NORVIR oral powder is indicated in combination with other antiretroviral agents for the treatment of pediatric patients with HIV-1 infection ( 1 )
AbbVie Inc.
OVAL WHITE A NK
A NK OVAL WHITE
DISCLAIMER:
"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."
"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."
"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."
PillSync may earn a commission via links on our site
16 HOW SUPPLIED/STORAGE AND HANDLING The package sizes, strengths, and storage and handling recommendations for NORVIR (
RITONAVIR) tablets, oral solution and oral powder are shown in the table below. NORVIR Tablets, 100 mg
RITONAVIR NORVIR Oral Solution, 80 mg per mL
RITONAVIR NORVIR Oral Powder, 100 mg Packet Presentation white film-coated ovaloid tablets debossed with the "a" logo and the code NK orange-colored liquid, in amber-colored, multi-dose bottles containing 600 mg
RITONAVIR per 7.5 mL marked dosage cup beige/pale yellow to yellow powder, in packets containing 100 mg of
RITONAVIR white film-coated ovaloid tablets debossed with “NK” on one side providing 100 mg
RITONAVIR. Packaging Size Bottles containing 30 tablets 240 mL bottles 30 foil/laminate, child-resistant packets per carton NDC Number 0074-3333-30 0074-1940-63 0074-3399-30 0074-2340-30 Recommended Storage Store at or below 30°C (86°F). Exposure to temperatures up to 50°C (122°F) for seven days permitted. Dispense in original container or USP equivalent tight container (60 mL or less). For patient use: exposure of this product to high humidity outside the original or USP equivalent tight container (60 mL or less) for longer than 2 weeks is not recommended. Store at room temperature 20°-25°C (68°-77°F). Do not refrigerate. Shake well before each use. Product should be stored and dispensed in the original container. Avoid exposure to excessive heat. Keep cap tightly closed. Store at or below 30°C (86°F).
More pills like OVAL A NK